Tenet Healthcare Files 8-K on Shareholder Votes

Ticker: THC · Form: 8-K · Filed: May 23, 2024 · CIK: 70318

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

TL;DR

TENET filed an 8-K for shareholder votes - standard procedure.

AI Summary

On May 22, 2024, Tenet Healthcare Corp. filed an 8-K to report on matters submitted to a vote of its security holders. The filing details the submission of various proposals for shareholder approval, as is standard procedure for corporate governance.

Why It Matters

This filing indicates routine corporate governance activities, providing transparency to shareholders regarding decisions put to a vote.

Risk Assessment

Risk Level: low — The filing pertains to routine shareholder votes and does not indicate any significant new risks or changes in the company's operations.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on matters submitted to a vote of Tenet Healthcare Corp.'s security holders.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is May 22, 2024.

What is the company's state of incorporation?

The company's state of incorporation is Nevada.

What is the address of Tenet Healthcare Corp.'s principal executive offices?

The address of Tenet Healthcare Corp.'s principal executive offices is 14201 Dallas Parkway, Dallas, TX 75254.

What is the registrant's telephone number?

The registrant's telephone number is (469) 893-2200.

Filing Stats: 650 words · 3 min read · ~2 pages · Grade level 11.6 · Accepted 2024-05-23 16:05:29

Key Financial Figures

Filing Documents

07

Item 5.07. Submission of Matters to a Vote of Security Holders. The 2024 Annual Meeting of Shareholders (the "Annual Meeting") of Tenet Healthcare Corporation (the "Company") was held on May 22, 2024 . Below are the final voting results from the meeting. 1. The Company's shareholders elected the following directors to serve on the Company's Board of Directors, each to serve until the next annual meeting of shareholders or until his or her successor is duly elected or qualified, whichever is later, or until the director's earlier resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES Saumya Sutaria 78,408,106 2,952,599 32,017 7,127,343 J. Robert Kerrey 79,073,669 2,287,690 31,364 7,127,343 Vineeta Agarwala 81,165,083 196,130 31,509 7,127,343 James L. Bierman 80,681,369 679,552 31,802 7,127,343 Roy Blunt 80,901,184 459,196 32,343 7,127,343 Richard W. Fisher 80,876,576 483,410 32,737 7,127,343 Meghan M. FitzGerald 79,983,800 1,373,328 35,595 7,127,343 Cecil D. Haney 80,749,317 612,662 30,744 7,127,343 Christopher S. Lynch 80,998,870 361,100 32,753 7,127,343 Richard J. Mark 80,881,920 478,921 31,882 7,127,343 Tammy Romo 80,830,618 530,853 31,252 7,127,343 Stephen H. Rusckowski 81,110,163 250,471 32,089 7,127,343 Nadja Y. West 80,637,096 723,225 32,401 7,127,343 2. The Company's shareholders approved, on an advisory basis, the Company's executive compensation: FOR AGAINST ABSTAIN BROKER NON-VOTES 78,324,154 2,920,906 147,662 7,127,343 3. The Company's shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accountants for the year ending December 31, 2024: FOR AGAINST ABSTAIN BROKER NON-VOTES 87,988,280 496,790 34,996 — 4. The shareholder proposal requesting a report on risk mitigation regarding state restrictions for emergency abortions did not pass. FOR AGAINST ABSTAIN BROKER NON-VOTES 4,059,525 75,912,077 1,421,120 7,127,343

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing